12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On
On May 27, Reuters reported that Biohub, a philanthropic venture formed by Meta CEO Mark Zuckerberg and Dr.
Posts Tagged ‘NYSE:NVS’
7 Best Longevity and Anti-Aging Stocks to Buy
The next frontier of human health may not be found in a hospital; it may be unlocked in a laboratory.
Novartis (NVS) Reports New Cosentyx® Data in Polymyalgia Rheumatica
Novartis AG (NYSE:NVS) is one of the best cheap stocks to buy for beginners. Novartis AG (NYSE:NVS) announced on June 3 new Cosentyx® data in polymyalgia rheumatica showing ...
Novartis (NVS) Positioned for Growth Through Transformative Innovations
Loomis Sayles, an investment management company, released its “Global Growth Fund” investor letter for the first quarter of 2026.
Novartis AG (NVS) Expands U.S. Manufacturing Footprint with New Texas Site
On May 7, NVS began construction on a 46,000-square-foot radioligand therapy manufacturing facility in Denton, Texas.
10 Best Cancer Stocks to Buy for the Long Term
Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.
14 Best Low Risk High Growth Stocks to Buy Right Now
The US economy is navigating a period of heightened volatility, defined by a sharp geopolitical tax on consumers and a resilient but stressed financial sector.
Novartis AG (NVS) Announces Final Two-Year Results From Phase III APPLAUSE‑IgAN Study
Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in now.
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Novartis AG (NYSE:NVS) is one of the top gene therapy stocks to buy according to hedge funds.
Top 10 Gene Therapy Stocks to Buy According to Hedge Funds
On February 23, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and tariff uncertainties.
Where is Novartis AG (NVS) Headed?
Novartis AG (NYSE:NVS) is one of the best immunotherapy stocks to buy according to hedge funds.
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets...
Novartis AG (NYSE:NVS) Q4 2025 Earnings Call Transcript
Operator: Good morning and good afternoon, and welcome to the Novartis Q4 Full Year 2025 Results Release Conference Call and Live Webcast.
Why Analysts Are Closely Watching Novartis AG (NVS)
Novartis AG (NYSE:NVS) is among the most profitable healthcare stocks to buy.
10 Most Profitable Healthcare Stocks to Buy
By far, the healthcare sector remains among the most resilient and profitable in global equity markets.
Jim Cramer is Optimistic About Novartis’ (NVS) Cancer Drug
Pharmaceutical firm Novartis AG (NYSE:NVS)’s shares are up by 44% over the past year and by 7.6% year-to-date. The tail end of 2025 saw several analysts discuss the firm.
14 Stocks on Jim Cramer’s Radar
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed OpenAI's ChatGPT and business applications.
Novartis AG (NVS) Advances $23B U.S. Investment Plan With New RLT Logistics Hub
TheFly reported on January 6 that Barclays upgraded NVS to Equal Weight from Underweight with a CHF 120 price target after a coverage transfer.
Top 10 Oncology Stocks to Buy Now
The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by 2034 with a compound annual growth rate of 11.75...
HSBC Lifts PT on Novartis AG (NVS) to $112 From $106
Novartis AG (NYSE:NVS) is one of the most profitable NYSE stocks to buy right now.
11 Most Profitable NYSE Stocks to Buy Right Now
On December 12, Adam Parker, Trivariate Research founder and CEO, appeared on CNBC’s ‘Squawk on the Street’ to talk about his view on the ‘buy high and sell low’ mantra...
Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report
Swiss pharmaceutical giant Novartis AG (NYSE:NVS) has entered into a massive $1.7 billion partnership with British pharmaceutical firm Relation Therapeutics to develop treatments...
13 Best ADR Stocks to Invest In
ADRs, or American Depository Receipts, are the US-listed securities of foreign firms that allow investors in America to buy and trade the shares within America.
Novartis AG (NVS) Gets Upgraded to Overweight from Neutral by JPMorgan
Novartis AG (NYSE:NVS) is one of the best pharma stocks to invest in. On December 8, Novartis AG (NYSE:NVS) was upgraded to Overweight from Neutral by JPMorgan.
11 Best Pharma Stocks to Invest In
CNBC reported on December 1 that the UK and US governments reached a deal on drug pricing.
Novartis AG (NVS) Announces US FDA Approval of Itvisma®
Novartis AG (NYSE:NVS) is one of the Most Undervalued Stocks to Buy Right Now.
10 Most Undervalued Stocks to Buy Right Now
S&P Global expects the US real GDP growth of 2% in 2025 and 2026, reflecting a marginal increase from its September forecast and slightly above its near-term potential growth.
TD Cowen Says Novartis (NVS) Has Strong Growth Path Through 2029
Novartis AG (NYSE:NVS) ranks among the best slow growth stocks to invest in. Following meetings with Novartis AG (NYSE:NVS)’s head of U.S.
12 Best Slow Growth Stocks to Invest In
On the night of November 27, during a week cut by Thanksgiving, stock futures saw minimal movement, with the Nasdaq Composite poised to end a seven-month winning run.
Morgan Stanley Upgrades Novartis (NVS) to Overweight, Raises Price Target to CHF 110
On October 31, Morgan Stanley upgraded Novartis AG (NYSE:NVS) to Overweight from Equal Weight, raising its price target to CHF 110 from CHF 108, ...
12 Best European Dividend Stocks to Buy Now
Dividend investing has been gaining traction among investors not only in the US but across global markets.
Novartis AG (NYSE:NVS) Q3 2025 Earnings Call Transcript
Operator: Good morning and good afternoon, and welcome to the Novartis Q3 2025 Results Release Conference Call and Live Webcast.
15 Stocks Were Recently Put Under the Microscope By Jim Cramer
“Bulls waste a huge amount of time shadowboxing the bears.
Novartis Receives FDA Approval for Rhapsido (remibrutinib) for Chronic Spontaneous Urticaria
Novartis (NYSE:NVS) is one of the best growth stocks to buy now. On September 30, Novartis announced the US FDA approval of its drug, Rhapsido (remibrutinib).
12 Best Growth Stocks to Buy Now
On October 1, Keith Lerner, Chief Investment Officer at Truist Wealth, appeared on CNBC and stated that the shutdown fears are muted, and investors are not overly concerned right...
11 Most Undervalued Growth Stocks to Buy According to Hedge Funds
On September 25, Stephen Parker, JPMorgan Private Bank's co-head of global investment strategy, joined CNBC for an interview to discuss the driving factors of the market.
Novartis AG (NVS) Strengthens Cardiovascular Unit with Tourmaline Bio Acquisition
Novartis AG (NYSE:NVS) is one of the best defensive stocks to buy, according to Steve Cohen.
10 Best Defensive Stocks to Buy According to Steve Cohen
Is it time to rebalance investment portfolios on equity valuations soaring with the S&P 500 powering through the 6,500 level? That’s the big question as uncertainty in the US...
Novartis (NVS) Strengthens Outlook With Ianalumab Trial Success and Leqvio Expansion
Novartis AG (NYSE:NVS) is a multinational pharmaceutical company focused on researching, developing, manufacturing, and marketing innovative medicines.
11 Best Annual Dividend Stocks to Buy According to Hedge Funds
Stability without compromising the returns has become the priority in today’s market.
Bernstein Maintains a Buy Rating on Novartis (NVS), Sets a CHF108 PT
Novartis AG (NYSE:NVS) is one of the top cheap pharmaceutical stocks to buy now.
11 Cheap Pharmaceutical Stocks to Buy Now
The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the steps they should take to decrease the prices of US prescription...
Novartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving [UPDATED]
Novartis AG (NYSE:NVS) is a Swiss pharmaceutical company that is one of the largest of its kind.
Novartis AG (NYSE:NVS) Q2 2025 Earnings Call Transcript
Operator: Good morning and good afternoon, and welcome to the Novartis Q2 2025 Results Release Conference Call and Live Webcast. [Operator Instructions].
Kisqali Emerges as Novartis AG (NVS) Blockbuster with Record Q2 Growth
Novartis AG (NYSE:NVS) is a Swiss pharmaceutical leader focused on developing innovative treatments across oncology, immunology, neuroscience, cardiovascular, and renal diseases...
10 Most Undervalued Pharma Stocks to Buy Now
Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs.
8 Stocks That Jim Cramer Recently Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed what bank industry executives were saying about President Trump removing Federal Reserve Chairman Jerome...
Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion
Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed the acquisition of Regulus Therapeutics.
Hedge Fund Resource Center
